| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |